Immunity booster on respiratory tract infections

An open label non comparative prospective clinical trial on the efficacy of BalRasayana syrup as an immunomodulator and its role in recurrent respiratory tract infections in children - IMB

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067252

Enrollment

Registered

2024-05-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J209- Acute bronchitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed as suffering from Vataja Pratishyaya on Ayurvedic parameters Age group of 3 to 16 years. Cardinal features of recurrent respiratory tract infections History of at least 3 episodes in the last six months

Exclusion criteria

Exclusion criteria: Individuals below 3 years and above 16 years Severe and Complicated respiratory allergic disorders like Bronchitis Pneumonia Tuberculosis Emphysema Lung abscess Bronchiectasis Patients who are diagnosed as Chronic asthma Nasal polyposis Congenital anomalies related to the respiratory system Patients on inhaled or systemic steroids Patients who are suspected of any of the diseases mentioned in exclusion criteria on the basis of history and examination will be excluded.

Design outcomes

Primary

Measure	Time frame
Improvement in symptoms of respiratory tracrt infections cough cold immunomodulation frequency of cough cold nasal discharge feverTimepoint: 6 weeks	—

Secondary

Measure	Time frame
Improvement in laboratory parameters improvement in hospitalization during treatment phaseTimepoint: 12 Weeks	—

Countries

India

Contacts

Public ContactDr Shubhangi Thakur

R A PODAR MEDICAL COLLEGE AYU WORLI MUMBAI

shubhangikthakur@gmail.com9404622180

Outcome results